Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy: A Comprehensive Guide

Edited by Vivek Asati PhD and Ankur Vaidya PhD, this book delves into the latest developments in cancer treatment, focusing on molecular targets that are genetically altered in cancer cells and crucial for tumor growth and survival.

Substantial research has been dedicated to creating targeted therapies that inhibit the action of pathogenic kinases, and clinical studies have confirmed the positive effects of kinase inhibitors in cancer treatment. This book explores various molecular targets, including:

• ALK2: Understanding its role in cancer development and potential therapeutic applications
• ATR: A promising target for cancer treatment and its current research landscape
• CK: The importance of casein kinase in cancer signaling pathways and potential inhibitors
• Src-Abl: The role of this kinase in cancer progression and available therapeutic strategies
• EGFR: Current insights into epidermal growth factor receptor targeting in cancer therapy
• Fyn-Blk-Lyn: The significance of these kinases in cancer cell signaling and potential inhibitors
• IGFs: Insulin-like growth factors as molecular targets in cancer treatment
• PAK1: The potential of p21-activated kinase 1 as a therapeutic target in cancer

Each chapter is written by experts actively working on these molecular targets, providing readers with a comprehensive understanding of how they can be utilized for novel cancer therapies.

This book is an invaluable resource for:

• Cancer researchers seeking to advance their understanding of molecular targets and their applications
• Oncologists looking to stay updated on the latest developments in cancer therapy
• Graduate students interested in the potential of novel cancer therapies based on molecular targets
• Members of the biomedical field seeking to explore the potential of heterocyclic compounds in cancer treatment

The book offers:

• A comprehensive compilation of recently discovered molecular targets for cancer therapy
• Updated literature on heterocyclic compounds, a crucial construction motif for the development of new anticancer drugs
• A thorough examination of recently introduced anticancer drugs, their health outcomes, and pharmacoeconomics

Publisher: Academic Press
Edition: 1st edition
Publication Date: May 3, 2024
Language: English
Pages: 502
ISBN-10: 0323961215
ISBN-13: 978-0323961219